Literature DB >> 29773673

Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Giorgia Di Lorenzo1, Renata Voltolini Velho1, Dominic Winter2, Melanie Thelen2, Shiva Ahmadi2, Michaela Schweizer3, Raffaella De Pace1, Kerstin Cornils4, Timur Alexander Yorgan5, Saskia Grüb1, Irm Hermans-Borgmeyer3, Thorsten Schinke5, Sven Müller-Loennies6, Thomas Braulke7, Sandra Pohl7.   

Abstract

Targeting of soluble lysosomal enzymes requires mannose 6-phosphate (M6P) signals whose formation is initiated by the hexameric N-acetylglucosamine (GlcNAc)-1-phosphotransferase complex (α2β2γ2). Upon proteolytic cleavage by site-1 protease, the α/β-subunit precursor is catalytically activated but the functions of γ-subunits (Gnptg) in M6P modification of lysosomal enzymes are unknown. To investigate this, we analyzed the Gnptg expression in mouse tissues, primary cultured cells, and in Gnptg reporter mice in vivo, and found high amounts in the brain, eye, kidney, femur, vertebra and fibroblasts. Consecutively we performed comprehensive quantitative lysosomal proteome and M6P secretome analysis in fibroblasts of wild-type and Gnptgko mice mimicking the lysosomal storage disorder mucolipidosis III. Although the cleavage of the α/β-precursor was not affected by Gnptg deficiency, the GlcNAc-1-phosphotransferase activity was significantly reduced. We purified lysosomes and identified 29 soluble lysosomal proteins by SILAC-based mass spectrometry exhibiting differential abundance in Gnptgko fibroblasts which was confirmed by Western blotting and enzymatic activity analysis for selected proteins. A subset of these lysosomal enzymes show also reduced M6P modifications, fail to reach lysosomes and are secreted, among them α-l-fucosidase and arylsulfatase B. Low levels of these enzymes correlate with the accumulation of non-degraded fucose-containing glycostructures and sulfated glycosaminoglycans in Gnptgko lysosomes. Incubation of Gnptgko fibroblasts with arylsulfatase B partially rescued glycosaminoglycan storage. Combinatorial treatments with other here identified missorted enzymes of this degradation pathway might further correct glycosaminoglycan accumulation and will provide a useful basis to reveal mechanisms of selective, Gnptg-dependent formation of M6P residues on lysosomal proteins.
© 2018 Di et al.

Entities:  

Keywords:  Affinity proteomics; Animal models; Enzyme modification; Gnptg-deficient mouse; Post-translational modifications; SILAC; arylsulfatase B; lysosomal missorting; lysosomal proteome; mannose 6-phospho-secretome

Mesh:

Substances:

Year:  2018        PMID: 29773673      PMCID: PMC6072544          DOI: 10.1074/mcp.RA118.000720

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  70 in total

1.  A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand β-glucocerebrosidase.

Authors:  Christina Zachos; Judith Blanz; Paul Saftig; Michael Schwake
Journal:  Traffic       Date:  2012-05-15       Impact factor: 6.215

2.  A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice.

Authors:  Sven Müller-Loennies; Giovanna Galliciotti; Katrin Kollmann; Markus Glatzel; Thomas Braulke
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.

Authors:  Kristoffer Weber; Udo Bartsch; Carol Stocking; Boris Fehse
Journal:  Mol Ther       Date:  2008-02-12       Impact factor: 11.454

4.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

5.  Tuberous sclerosis, polycystic kidney disease and mucolipidosis III gamma caused by a microdeletion unmasking a recessive mutation.

Authors:  Jaime J Barea; Eline van Meel; Stuart Kornfeld; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2015-06-24       Impact factor: 2.802

6.  Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities.

Authors:  Kasmintan A Schrader; Alireza Heravi-Moussavi; Paula J Waters; Janine Senz; James Whelan; Gavin Ha; Patrice Eydoux; Torsten Nielsen; Barry Gallagher; Arusha Oloumi; Niki Boyd; Bridget A Fernandez; Terry-Lynn Young; Steven Jm Jones; Martin Hirst; Sohrab P Shah; Marco A Marra; Jane Green; David G Huntsman
Journal:  J Pathol       Date:  2011-09       Impact factor: 7.996

7.  Mucolipidosis III (pseudo-Hurler polydystrophy); clinical studies in aged patients in one family.

Authors:  F Umehara; W Matsumoto; M Kuriyama; K Sukegawa; S Gasa; M Osame
Journal:  J Neurol Sci       Date:  1997-03-10       Impact factor: 3.181

8.  Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients.

Authors:  T E Kelly; G H Thomas; H A Taylor; V A McKusick; W S Sly; J H Glaser; M Robinow; L Luzzatti; C Espiritu; M Feingold; M J Bull; E M Ashenhurst; E J Ives
Journal:  Johns Hopkins Med J       Date:  1975-10

9.  Is movement of mannose 6-phosphate-specific receptor triggered by binding of lysosomal enzymes?

Authors:  T Braulke; C Gartung; A Hasilik; K von Figura
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

10.  Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions.

Authors:  Takanobu Otomo; Michaela Schweizer; Katrin Kollmann; Valéa Schumacher; Nicole Muschol; Eva Tolosa; Hans-Willi Mittrücker; Thomas Braulke
Journal:  J Cell Biol       Date:  2015-01-19       Impact factor: 10.539

View more
  11 in total

1.  Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.

Authors:  Wiebke Sachs; Marlies Sachs; Elke Krüger; Stephanie Zielinski; Oliver Kretz; Tobias B Huber; Anke Baranowsky; Lena Marie Westermann; Renata Voltolini Velho; Nataniel Floriano Ludwig; Timur Alexander Yorgan; Giorgia Di Lorenzo; Katrin Kollmann; Thomas Braulke; Ida Vanessa Schwartz; Thorsten Schinke; Tatyana Danyukova; Sandra Pohl; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

2.  Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking.

Authors:  Carolin Schmidtke; Stephan Tiede; Melanie Thelen; Reijo Käkelä; Sabrina Jabs; Georgia Makrypidi; Marc Sylvester; Michaela Schweizer; Ingke Braren; Nahal Brocke-Ahmadinejad; Susan L Cotman; Angela Schulz; Volkmar Gieselmann; Thomas Braulke
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

3.  Clinical, radiological and computational studies on two novel GNPTG variants causing mucolipidosis III gamma phenotypes with varying severity.

Authors:  Mustafa Doğan; Recep Eröz; Kerem Terali; Alper Gezdirici; Semih Bolu
Journal:  Mol Biol Rep       Date:  2021-01-28       Impact factor: 2.316

4.  Structures of the mannose-6-phosphate pathway enzyme, GlcNAc-1-phosphotransferase.

Authors:  Alexei Gorelik; Katalin Illes; Khanh Huy Bui; Bhushan Nagar
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

Review 5.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

6.  Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation.

Authors:  Leonie von Elsner; Guoliang Chai; Pauline E Schneeberger; Frederike L Harms; Christian Casar; Minyue Qi; Malik Alawi; Ghada M H Abdel-Salam; Maha S Zaki; Florian Arndt; Xiaoxu Yang; Valentina Stanley; Maja Hempel; Joseph G Gleeson; Kerstin Kutsche
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

7.  The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells.

Authors:  Weihua Tian; Zilu Ye; Shengjun Wang; Morten Alder Schulz; Julie Van Coillie; Lingbo Sun; Yen-Hsi Chen; Yoshiki Narimatsu; Lars Hansen; Claus Kristensen; Ulla Mandel; Eric Paul Bennett; Siamak Jabbarzadeh-Tabrizi; Raphael Schiffmann; Jin-Song Shen; Sergey Y Vakhrushev; Henrik Clausen; Zhang Yang
Journal:  Nat Commun       Date:  2019-04-30       Impact factor: 14.919

8.  Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders.

Authors:  Ying Zeng; Xu He; Tatyana Danyukova; Sandra Pohl; Allison R Kermode
Journal:  J Clin Med       Date:  2019-12-12       Impact factor: 4.241

Review 9.  The rapidly evolving view of lysosomal storage diseases.

Authors:  Giancarlo Parenti; Diego L Medina; Andrea Ballabio
Journal:  EMBO Mol Med       Date:  2021-01-18       Impact factor: 12.137

10.  Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.

Authors:  Lena Marie Westermann; Lutz Fleischhauer; Jonas Vogel; Zsuzsa Jenei-Lanzl; Nataniel Floriano Ludwig; Lynn Schau; Fabio Morellini; Anke Baranowsky; Timur A Yorgan; Giorgia Di Lorenzo; Michaela Schweizer; Bruna de Souza Pinheiro; Nicole Ruas Guarany; Fernanda Sperb-Ludwig; Fernanda Visioli; Thiago Oliveira Silva; Jamie Soul; Gretl Hendrickx; J Simon Wiegert; Ida V D Schwartz; Hauke Clausen-Schaumann; Frank Zaucke; Thorsten Schinke; Sandra Pohl; Tatyana Danyukova
Journal:  Dis Model Mech       Date:  2020-11-18       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.